Navigation Links
UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012
Date:5/18/2012

the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

Forward Looking Statement
This press release contains forward-looking statements based on current plans, estimates and beliefs of management. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial information, expected legal, political, regulatory or clinical results and other such estimates and results. By their nature, such forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions which could cause actual results to differ materially from those that may be implied by such forward-looking statements contained in this press release. Important factors that could result in such differences include: changes in general economic, business and competitive conditions, the inability to obtain necessary regulatory approvals or to obtain them on acceptable terms, costs associated with research and development, changes in the prospects for products in the pipeline or under development by UCB, effects of future judicial decisions or governmental investigations, product liability claims, challenges to patent protection for products or product candidates, changes in laws or regulations, exchange rate fluctuations,  changes or uncertainties in tax laws or the administration of such laws and hiring and retention of its employees.  UCB is providing this information as of the date of this press release and expressly disclaims any duty to update any information contained in this press release, e
'/>"/>

SOURCE UCB, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. White Smile Global Inc. Proudly Announces the Introduction of a New Innovative White Smile® Professional™ Dental "In-Office" Teeth Whitening Kit
2. UCB Proudly Reinforces Long-Standing Commitment to Patients and Physicians at American College of Gastroenterology 2011 Annual Scientific Meeting
3. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
4. Data Analysis Reinforces the Safety Profile of Levemir(R)
5. Data Presented on Cempra Pharmaceuticals CEM-101 at the Infectious Diseases Society of America Annual Meeting Reinforces Potency and Coverage Against Multidrug-Resistant S. Pneumoniae Isolates
6. New Data Reinforces the Proven Safety and Effectiveness of the BIRMINGHAM HIP Resurfacing System
7. New Data Reinforces Safety Profile of Abbotts Market-Leading XIENCE V(R) Drug Eluting Stent
8. Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®
9. Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial Resistance
10. Aptuit Completes Sale of CTS to Catalent; Reinforces Commitment to Scientific Excellence and Most Comprehensive Early to Mid-Phase Development Capability
11. New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Prostate cancer is the second leading cause of cancer ... caught early - the problem is that too often ... Conditions Education Council (PCEC), – a national organization ... cancer screening –  is sponsoring its 25 th ... Committed to encouraging men to take ...
(Date:9/22/2014)... , Sept. 22, 2014 CytRx Corporation ... development company specializing in oncology, today announced that study ... clinical trials of aldoxorubicin, a pivotal global Phase 3 ... a global Phase 2b clinical trial in small cell ... for Medical Oncology (ESMO) 2014 Congress being held September ...
(Date:9/19/2014)... CHAPEL HILL, N.C. , Sept. 19, 2014 ... critical role in forging relationships with key opinion ... the market and competition. Despite the critical nature ... has created many challenges, including altering the landscape ... According to research, the oversight ...
Breaking Medicine Technology:PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 2PCEC Encourages Men Across America to Have a Baseline Prostate Health Assessment During the Annual Prostate Cancer Awareness Week 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 2CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 3CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 4CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 5CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress 6Role of Medical Science Liaisons Shifting in Healthcare Industry 2
... the annual,meeting of the Pediatric Academic Societies (PAS) shows ... the start of the typical flu,vaccination season -- healthcare ... children are already in the doctor,s office.,The potential impact ... that less than 20 percent of school-aged children between ...
... May 5 N30 Pharma (N30), a,biopharmaceutical company ... that target endogenous s-nitrosothiols,announced today that it has ... with mild to moderate asthma, as well as ... treatment of reactive and,obstructive airway diseases, including Cystic ...
Cached Medicine Technology:Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 2Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 3Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors' Visits 4N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201 2
(Date:9/22/2014)... three-quarters (74%) of parents are aware of online ... (28%) have used those online ratings to choose ... U-M research published today in Pediatrics . ... Children,s Hospital National Poll on Children,s Health, researchers ... physicians influenced their choices in seeking healthcare providers ...
(Date:9/22/2014)... a drug commonly used to treat diabetes, may raise ... among patients with an underactive thyroid, a new study ... may be associated with heart problems and broken bones, ... study. Among those in the study with an ... levels of thyroid-stimulating hormone per year compared with 322 ...
(Date:9/22/2014)... “The Race is On!” for the 22nd ... October 12, 2014 as it moves to its new location ... the signature fundraising and awareness event for Susan G. Komen® ... Race for the Cure provides supporters of all ages an ... even sleeping in. , “Moving the Race to Cesar ...
(Date:9/22/2014)... University of North Carolina at Chapel Hill researchers represents ... people who are experiencing the earliest stages of psychosis. ... development of severe mental disorders such as schizophrenia. Schizophrenia ... about 1 in every 100 people. In severe cases, ... life compromised, and the burden on family members can ...
(Date:9/22/2014)... Calif. The University of California, Riverside is one ... total of $2.5 million by the National ... zygomycetes ancient lineages of fungi that include plant ... wide variety of organic compounds. , Zygomycetes, used in ... to be among the first terrestrial fungi. Symbiotic associations ...
Breaking Medicine News(10 mins):Health News:Online ratings influence parents' choices of physicians for their children 2Health News:Diabetes Drug Metformin May Affect Thyroid in Some Patients 2Health News:22nd Annual Susan G. Komen Phoenix Race for the Cure® 2014 Moves to Downtown Phoenix 2Health News:22nd Annual Susan G. Komen Phoenix Race for the Cure® 2014 Moves to Downtown Phoenix 3Health News:Blood test may help determine who is at risk for psychosis 2Health News:Project launched to study evolutionary history of fungi 2Health News:Project launched to study evolutionary history of fungi 3Health News:Project launched to study evolutionary history of fungi 4
... has decided to include Genentech's breast cancer drug, Herceptin ... drug will now be subsidized throughout Australia. ... Australian women would be eligible to start using the ... the government about A$470 million ($356 million) by 2009. ...
... Since the start of the one child family policy in ... decreased, and a gross imbalance in the sex ratio// has ... ,The one child family policy has been in force in ... measure. To examine the impact of this policy, researchers analysed ...
... the Royal Adelaide Hospital may have found a cheap, ... aged care from becoming vitamin D deficient.// ... in the latest edition of the Medical Journal of ... Cleland, Clinical Professor at the Department of Medicine, University ...
... President of the Canadian Medical Association (CMA) said that Canadian ... health of their own children// although in general they rated ... to a survey carried out by Ipsos-Reid, commissioned by the ... kids aged 2-17 are obese/overweight, however only 9% of Canadian ...
... new warnings about the risk of psychotic behavior, heart ... on Monday. ,These drugs include Novartis ... Administration spokeswoman, Susan Bro said. ,She ... pressure. They must also include warnings about the risk ...
... shot on his family’s farm near Stowmarket Suffolk, has caused ... rabbit flu.// ,John Freeman, 29, had become infected ... a rabbit on his farm. His mother explained that he ... after three days. ,It was revealed by the ...
Cached Medicine News:Health News:Lower Birth Rate and Fewer Girls under China’s one Child Polic 2Health News:Improving Vitamin D Levels in Aged Care Residents 2Health News:New Alerts Needed for ADHD drugs 2
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
... an electrical power supply, MERKUR offers a broad ... a gas spring for ease of operation. For ... a foot pedal hydraulic system. Thanks to its ... anytime in a highly mobile and flexible manner. ...
... table MARS Enduro is the ideal ... are required before, during or directly ... motorised longitudinal adjustment and the filigreed ... conditions in examination, induction and operating ...
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
Medicine Products: